Free Trial

Titan Pharmaceuticals (TTNP) SEC Filings & 10K Form

Titan Pharmaceuticals logo
$3.99 -0.74 (-15.64%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$4.00 +0.01 (+0.23%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Titan Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/26/2025
3:05 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2025
11:28 AM
Titan Pharmaceuticals (Filer)
Form DEFA14A
08/14/2025
4:16 PM
Titan Pharmaceuticals (Filer)
Form DEFA14A
07/22/2025
4:04 PM
Titan Pharmaceuticals (Filer)
Form DEFM14A
07/22/2025
4:06 PM
Titan Pharmaceuticals (Filer)
Form DEFA14A
06/18/2025
3:49 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
4:25 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
4:25 PM
Titan Pharmaceuticals (Subject)
Form 425
06/02/2025
4:20 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2025
12:50 PM
Loh Gabriel (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/02/2025
3:05 PM
Titan Pharmaceuticals (Filer)
Form DEF 14A
04/22/2025
3:45 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
3:30 PM
Titan Pharmaceuticals (Filer)
Form PRE 14A
04/16/2025
2:49 PM
Jye Chay Weei (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2025
3:30 PM
Titan Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/08/2025
3:05 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:10 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
8:16 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TTNP) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners